Intercept Pharmaceuticals Incの収益YQ/Q
Intercept Pharmaceuticals Incの収益YQ/Qは何ですか。
Intercept Pharmaceuticals Incの収益YQ/Qは14.44%です。
収益YQ/Qの定義は何ですか。
四半期収益成長率、前年比は、前年同期の業績と比較して、売上高の増加率がパーセンテージとして表されています。
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
NASDAQのセクタHealth Careにおける収益YQ/Qの企業と比べるIntercept Pharmaceuticals Inc
Intercept Pharmaceuticals Incは何をしますか。
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Intercept Pharmaceuticals Incと類似の収益yq/q
- Mediland Pharmの収益YQ/Qは14.41%です。
- Greenply Industriesの収益YQ/Qは14.41%です。
- BCIの収益YQ/Qは14.41%です。
- Morgan Sindall plcの収益YQ/Qは14.42%です。
- Bharat Gearsの収益YQ/Qは14.42%です。
- Meituan Dianpingの収益YQ/Qは14.42%です。
- Intercept Pharmaceuticals Incの収益YQ/Qは14.44%です。
- Pool Dl ,001の収益YQ/Qは14.45%です。
- Gujarat Pipavav Portの収益YQ/Qは14.45%です。
- Gujarat Pipavav Portの収益YQ/Qは14.45%です。
- S&P Global Incの収益YQ/Qは14.45%です。
- Cohen & Steers Quality Income Realty Fundの収益YQ/Qは14.45%です。
- Aeerisの収益YQ/Qは14.45%です。